scroll to explore

scroll to explore icon

Why should managing gMG mean opening Pandora's box?

Management of generalized myasthenia gravis (gMG) is complicated. It often requires multiple approaches and monitoring, which can severely impact patients' quality of life.1-4

What does the burden of gMG really mean for patients? 

SHOW ME
hero

FcRn: A critical role

gMG is an autoimmune disorder of the musculoskeletal system caused by pathogenic immunoglobulin G (IgG) autoantibodies.1

Studies have explored targeting the neonatal Fc receptor (FcRn), as it plays a critical role in gMG by prolonging the half-life of IgG antibodies, including pathogenic antibodies.5,6

IgG autoantibodies binding to FcRn
IgG autoantibody

FcRn: A critical role

gMG is an autoimmune disorder of the musculoskeletal system caused by pathogenic immunoglobulin G (IgG) autoantibodies.1

Studies have explored targeting the neonatal Fc receptor (FcRn), as it plays a critical role in gMG by prolonging the half-life of IgG antibodies, including pathogenic antibodies.5,6

IgG autoantibody
background

Managing gMG may unleash serious consequences3,4

Learn more about the implications for patients’ physical and psychological well-being.

GET THE FACTS

References: 1. Gotterer L, Li Y. J Neurol Sci. 2016;369:294-302. doi:10.1016/j.jns.2016.08.057 2. Guo Y et al. Front Immunol. 2018;9:1299. doi:10.3389/fimmu.2018.01299 3. Liu D et al. Allergy Asthma Clin Immunol. 2013;9(1):30. doi:10.1186/1710-1492-9-30 4. Gilhus NE et al. Nat Rev Dis Primers. 2019;5(1):30. doi:10.1038/s41572-019-0079-y 5. Roopenian DC, Akilesh S. Nat Rev Immunol. 2007;7(9):715-725. doi:10.1038/nri2155 6. Ward ES, Ober RJ. Trends Pharmacol Sci. 2018;39(10):892-904. doi:10.1016/j.tips.2018.07.007

close

Stay connected! Join us to receive more information about gMG